Change search
ReferencesLink to record
Permanent link

Direct link
Neurofilament Levels as Biomarkers in Asymptomatic and Symptomatic Familial Amyotrophic Lateral Sclerosis
Show others and affiliations
2016 (English)In: Annals of Neurology, ISSN 0364-5134, E-ISSN 1531-8249, Vol. 79, no 1, 152-158 p.Article in journal (Refereed) PublishedText
Abstract [en]

Neurofilaments are elevated in the cerebrospinal fluid (CSF) and serum of amyotrophic lateral sclerosis (ALS) patients. However, timing of this increase is unknown. To characterize the premanifest disease phase, we performed a cross-sectional study on asymptomatic (n=12) and symptomatic (n=64) ALS mutation carriers and family controls (n=19). Neurofilaments NF-L (neurofilament-light chain) and pNF-H (phosphorylated neurofilament-heavy chain) are normal before symptom onset and increased by at least an order of magnitude at early symptom onset in CSF (pNF-H) or serum and CSF (NF-L). Thus, blood and CSF neurofilament levels are linked to the symptomatic phase of ALS and might serve as objective markers of structural damage to the nervous system.

Place, publisher, year, edition, pages
2016. Vol. 79, no 1, 152-158 p.
National Category
URN: urn:nbn:se:umu:diva-118422DOI: 10.1002/ana.24552ISI: 000370642600016PubMedID: 26528863OAI: diva2:917370
Available from: 2016-04-06 Created: 2016-03-18 Last updated: 2016-04-06Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Andersen, Peter M.
By organisation
Department of Pharmacology and Clinical Neuroscience
In the same journal
Annals of Neurology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 19 hits
ReferencesLink to record
Permanent link

Direct link